Novo Nordisk

Ozempic® is the GLP-1 with the most FDA-approved uses for patients with type 2 diabetes including, improvement of…

“Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…

Novo Nordisk A/S Bagsværd, Denmark, 12 August 2025 — This company announcement discloses the data of the transaction(s) made…

Novo Nordisk A/S Bagsværd, Denmark, 8 August 2025 — This company announcement discloses the data of the transaction(s) made…

Wegovy is now available in Singapore more than two years after it was approved by the Health Sciences…

Pfizer and Novo Nordisk have underperformed the market over the past year. But both should remain major players…

Daniel Drucker, 68, speaks a little Spanish at the BBVA Foundation headquarters in Bilbao, Spain, where he’s about…

Quantum technology is becoming very important for both business and global power. In the last ten years, the…

BEIJING, July 18, 2025 /PRNewswire/ — Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare…

WERNERSVILLE, Pa. — To make sense of the reds and greens dancing across a computer monitor displaying a…

Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines